Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

CpG DNA and LPS induce distinct patterns of activation in human monocytes

Gene Therapy volume 6, pages 893–903 (1999)Cite this article

Abstract

A specific set of immune functions is switched on in response to DNA containing unmethylated CpG dinucleotides in particular base contexts (‘CpG motifs’). Plasmids, viral vectors and antisense oligodeoxynucleotides used for DNA vaccination, gene replacement or gene blockade contain immunostimulatory CpG motifs which may have independent biological activity. Although the immune stimulatory effects of CpG motifs on murine cells are well established, the evaluation of their possible effects on human cells is complicated by the higher LPS sensitivity of human leukocytes compared with those in mice. To address this issue, we analyzed CpG- and LPS-mediated immune activation of human PBMC. The biologic activity of LPS could be detected within 4 h using intracellular TNF staining of monocytes with flow cytometry at concentrations just one-twentieth (0.0014 EU/ml) of the lower detection limit for the routinely used LAL assay (0.03 EU/ml). In contrast to the rapid LPS response, CpG DNA-stimulated TNF and IL-6 synthesis in human mono- cytes was not detectable until 18 h. E. coli DNA induced IL-6 synthesis in a concentration-dependent manner (30 μg/ml E. coli DNA: 409 pg/ml ± 75 pg/ml, n = 7, IL-6 ELISA), but calf thymus DNA did not (<10 pg/ml). likewise, the cpg oligodeoxynucleotides 1760 (phospho- rothioate) and 2059 (unmodified) induced il-6 synthesis, but the corresponding control oligonucleotides 1908 and 2077 did not. cpg dna and lps enhanced il-6 synthesis synergistically. icam-1-expression of monocytes was increased 4.6-fold by e. coli dna, 3.5-fold by 1760 and three-fold by 2059, compared with 3.6-fold by a maximal lps stimulus and no change with non-cpg dna. in conclusion, cpg-motifs induce tnf, il-6 and icam-1 expression in human monocytes, but the kinetics of this differ from that induced by lps, which makes it possible to distinguish immune activation by these agents. these results have important implications for the clinical development of therapeutic dna in humans.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10

Similar content being viewed by others

References

  1. Davis HL . Plasmid DNA expression systems for the purpose of immunization Curr Opin Biotechnol 1997 8: 635–646

    Article  CAS  Google Scholar 

  2. Hartmann G et al. Specific suppression of human tumor necrosis factor-alpha synthesis by antisense oligodeoxynucleotides Antisense Nucleic Acid Drug Dev 1996 6: 291–299

    Article  CAS  Google Scholar 

  3. Branch AD . A good antisense molecule is hard to find Trends Biochem Sci 1998 23: 45–50

    Article  CAS  Google Scholar 

  4. Agrawal S, Iyer RP . Perspectives in antisense therapeutics Pharmacol Ther 1997 76: 151–160

    Article  CAS  Google Scholar 

  5. Krieg AM et al. CpG motifs in bacterial DNA trigger direct B-cell activation Nature 1995 374: 546–549

    Article  CAS  Google Scholar 

  6. Krieg AM, Yi AK, Schorr J, Davis HL . The role of CpG dinucleotides in DNA vaccines Trends Microbiol 1998 6: 23–27

    Article  CAS  Google Scholar 

  7. Krieg AM . An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA J Lab Clin Med 1996 128: 128–133

    Article  CAS  Google Scholar 

  8. Krieg AM . Lymphocyte activation by CpG dinucleotide motifs in prokaryotic DNA Trends Microbiol 1996 4: 73–76

    Article  CAS  Google Scholar 

  9. Sato Y et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization Science 1996 273: 352–354

    Article  CAS  Google Scholar 

  10. Klinman DM, Yamshchikov G, Ishigatsubo Y . Contribution of CpG motifs to the immunogenicity of DNA vaccines J Immunol 1997 158: 3635–3639

    CAS  PubMed  Google Scholar 

  11. Hartmann G et al. Cytokines and therapeutic oligonucleotides Cytok Cell Molec Ther 1997 3: 247–256

    CAS  Google Scholar 

  12. Krieg A . How to exclude immunostimulatory effects of antisense oligonucleotides. In: Hartmann G, Endres S (eds). Manual of Antisense Methodology Kluwer Academic: Boston 1999 (in press

  13. Moldoveanu Z, Love-Homan L, Huang WQ, Krieg AM . CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus Vaccine 1998 16: 1216–1224

    Article  CAS  Google Scholar 

  14. Davis HL et al. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen J Immunol 1998 160: 870–876

    CAS  PubMed  Google Scholar 

  15. Weiner GJ et al. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization Proc Natl Acad Sci USA 1997 94: 10833–10837

    Article  CAS  Google Scholar 

  16. Wooldridge JE, Ballas Z, Krieg AM, Weiner GJ . Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma Blood 1997 89: 2994–2998

    CAS  PubMed  Google Scholar 

  17. Roman M et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants Nature Med 1997 3: 849–854

    Article  CAS  Google Scholar 

  18. Chu RS et al. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity J Exp Med 1997 186: 1623–1631

    Article  CAS  Google Scholar 

  19. Kline JN et al. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma J Immunol 1998 160: 2555–2559

    CAS  PubMed  Google Scholar 

  20. Krieg AM, Love-Homan L, Yi AK, Harty JT . CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge J Immunol 1998 161: 2428–2434

    CAS  PubMed  Google Scholar 

  21. Zimmermann S et al. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis J Immunol 1998 160: 3627–3630

    CAS  PubMed  Google Scholar 

  22. Freund J, Casals J, Hosmer EP . Sensitization and antibody formation after injection of tubercle bacilli and paraffin oil Proc Soc Exp Biol Med 1937 37: 509–513

    Article  CAS  Google Scholar 

  23. Freund J, McDermot K . Sensitization to horse serum by means of adjuvants Proc Soc Exp Bio NY 1942 49: 548–553

    Article  CAS  Google Scholar 

  24. Herbert WJ . Mineral-oil adjuvants and the immunization of laboratory animals. In: Weir DM (ed) . Handbook of Experimental Immunology Blackwell Scientific: Oxford 1978 179–193

    Google Scholar 

  25. Yamamoto S et al. DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth Microbiol Immunol 1992 36: 983–997

    Article  CAS  Google Scholar 

  26. Messina JP, Gilkeson GS, Pisetsky DS . Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA J Immunol 1991 147: 1759–1764

    CAS  PubMed  Google Scholar 

  27. Munoz J . Effect of bacteria and bacterial products on antibody response Adv Immunol 1964 4: 397–440

    Article  CAS  Google Scholar 

  28. Stacey KJ, Sweet MJ, Hume DA . Macrophages ingest and are activated by bacterial DNA J Immunol 1996 157: 2116–2122

    CAS  PubMed  Google Scholar 

  29. Sweet MJ et al. IFN-gamma primes macrophage responses to bacterial DNA J Interferon Cytok Res 1998 18: 263–271

    Article  CAS  Google Scholar 

  30. Lamont AG, Adorini L . IL-12: a key cytokine in immune regulation Immunol Today 1996 17: 214–217

    Article  CAS  Google Scholar 

  31. Eigler A, Sinha B, Hartmann G, Endres S . Taming TNF: strategies to restrain this proinflammatory cytokine Immunol Today 1997 18: 487–492

    Article  CAS  Google Scholar 

  32. Chace JH et al. Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12 Clin Immunol Immunopathol 1997 84: 185–193

    Article  CAS  Google Scholar 

  33. Cowdery JS, Chace JH, Yi AK, Krieg AM . Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides J Immunol 1996 156: 4570–4575

    CAS  PubMed  Google Scholar 

  34. Ballas ZK, Rasmussen WL, Krieg AM . Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA J Immunol 1996 157: 1840–1845

    CAS  PubMed  Google Scholar 

  35. Yi AK, Chace JH, Cowdery JS, Krieg AM . IFN-gamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides J Immunol 1996 156: 558–564

    CAS  PubMed  Google Scholar 

  36. Yi AK et al. Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway J Immunol 1996 157: 5394–5402

    CAS  PubMed  Google Scholar 

  37. Klinman DM et al. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma Proc Natl Acad Sci USA 1996 93: 2879–2883

    Article  CAS  Google Scholar 

  38. Macfarlane DE, Manzel L . Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds J Immunol 1998 160: 1122–1131

    CAS  PubMed  Google Scholar 

  39. Yamamoto T et al. Synthetic oligonucleotides with certain palindromes stimulate interferon production of human peripheral blood lymphocytes in vitro Jpn J Cancer Res 1994 85: 775–779

    Article  CAS  Google Scholar 

  40. Liang H et al. Activation of human B cells by phosphorothioate oligodeoxynucleotides J Clin Invest 1996 98: 1119–1129

    Article  CAS  Google Scholar 

  41. Branda RF et al. B-cell proliferation and differentiation in common variable immunodeficiency patients produced by an antisense oligomer to the rev gene of HIV-1 Clin Immunol Immunopathol 1996 79: 115–121

    Article  CAS  Google Scholar 

  42. Branda RF et al. Amplification of antibody production by phosphorothioate oligodeoxynucleotides J Lab Clin Med 1996 128: 329–338

    Article  CAS  Google Scholar 

  43. Yi AK et al. CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species J Immunol 1998 160: 4755–4761

    CAS  PubMed  Google Scholar 

  44. Gao JX et al. Generation of dendritic cell-like antigen-presenting cells in long-term mixed leucocyte culture: phenotypic and functional studies Immunology 1997 91: 135–144

    Article  CAS  Google Scholar 

  45. Yacyshyn BR et al. A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn’s disease Gastroenterology 1998 114: 1133–1142

    Article  CAS  Google Scholar 

  46. Ohta Y et al. Direct antigen presentation through binding of donor intercellular adhesion molecule-1 to recipient lymphocyte function-associated antigen-1 molecules in xenograft rejection Transplantation 1998 65: 1094–1100

    Article  CAS  Google Scholar 

  47. Taguchi M et al. Patterns for RANTES secretion and intercellular adhesion molecule 1 expression mediate transepithelial T cell traffic based on analyses in vitro and in vivo J Exp Med 1998 187: 1927–1940

    Article  CAS  Google Scholar 

  48. Sparwasser T et al. Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock Eur J Immunol 1997 27: 1671–1679

    Article  CAS  Google Scholar 

  49. Schwartz DA et al. CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract J Clin Invest 1997 100: 68–73

    Article  CAS  Google Scholar 

  50. Sartor RB . Review article: how relevant to human inflammatory bowel disease are current animal models of intestinal inflammation? Aliment Pharmacol Ther 1997 3: 89–96

    Google Scholar 

  51. Elson CO, Sartor RB, Tennyson GS, Riddel RH . Experimental models of inflammatory bowel disease Gastroenterology 1995 109: 1344–1367

    Article  CAS  Google Scholar 

  52. Sun S, Kishimoto H, Sprent J . DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen J Exp Med 1998 187: 1145–1150

    Article  CAS  Google Scholar 

  53. Hartmann G, Krug A, Waller-Fontaine K, Endres S . Oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor: dependence on phosphorothioate modification and reversal by heparin Mol Med 1996 2: 429–438

    Article  CAS  Google Scholar 

  54. Hartmann G et al. Spontaneous and cationic lipid-mediated uptake of antisense oligonucleotides in human monocytes and lymphocytes J Pharmacol Exp Ther 1998 285: 920–928

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University of Iowa, Iowa City, IA, USA

    G Hartmann & A M Krieg

  2. Veteran Affairs Medical Center, Iowa City, IA, USA

    A M Krieg

Authors
  1. G Hartmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A M Krieg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hartmann, G., Krieg, A. CpG DNA and LPS induce distinct patterns of activation in human monocytes. Gene Ther 6, 893–903 (1999). https://doi.org/10.1038/sj.gt.3300880

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3300880

Keywords

This article is cited by

Search

Advanced search

Quick links